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There is increasing evidence that immunological mechanisms are involved in a
iderable number ofdisease processes ofthe central nervous system (CNS). Thereby
persistent viral infections of the brain have gained special interest, e.g., HIV-1 in
the AIDS dementia complex (1), measles virusin subacute sclerosing panencephalitis
(2), and BK papovavirus in progressive multifocal leukoencephalopathy (3, 4). Borna
disease (BD), which we used as a model for a persistent virus infection of the CNS,
is caused by a highly neurotropic, but yet only partially characterized virus, which
has been shown to spread exclusively by the axonal route. BD naturally occurs en-
demically in individual horses and sheep as a progressive encephalopathy. After a
widely variable incubation time, which can span a few weeks to many months, the
disease becomes apparent as disturbances of motility and in sensoric functions fol-
lowed by paralysis and death. Pathological lesions are restricted to the CNS, con-
sisting ofperivascular infiltrations oflymphocytes and other mononuclear cells, pre-
dominantly in the grey matter of the brain. A broad spectrum of animals ranging
from chickens to primates can be infected experimentally. Depending on the host
species and the virus strain used for infection, the disease becomes apparent as pa-
ralysis followed by death or the disease remains inapparent or becomes evident only
by obesity and disturbancy in fertility or behavioral abnormalities (5). With the virus
strain used in this study, rats develop an acute encephalitis by day 20, which is fol-
lowed by an apathic phase that can last life-long. BD virus-specific antibodies have
recently been found in sera ofpsychiatric patients (6). In rats, it has previously been
shown that the pathogenesis of BD is due to a virus-induced cell-mediated immune
mechanism. Neonatally infected rats or rats immunosuppressed after infection, e.g.,
with cyclophosphamide, do not develop the disease or histopathological alterations,
despite high level ofvirus persisting in the CNS. Adoptive transfer ofcells from the
spleen or lymph nodes from diseased rats to the tolerant recipients induced enceph-
alitis and clinical manifestation of the disease (7).
In this article we describe the in vitro and in vivo propertiesofa T cell line specific
for a BD virus antigen and we show its immunopathological relevance.
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Materials and Methods
Virus, Rats, and Infection.
￿
Throughout the study the Giessen strain HE/80 ofBD virus
was used (8). Lewis rats purchased from the Zentralinstitut fûr Versuchstierzucht, Han-
nover, FRG, were infected intracerebrally with 6 x 10 4 ID50 .
Induction and Cultivation ofthe T Cell Line NMI .
￿
For the induction of a BD virus-specific
T cell, Lewis rats 8-10 wk old were immunized by inoculation of 60 Kg of the purified BD
virus-specific 38/39-kD antigen (9) in IFA into the hind footpads . 10 d later cells from the
regional lymph node were restimulated in vitro with the same antigen . Restimulations of
T cells (2 x 105/ml) were performed in the presence of syngenic thymocytes (2 x 107/ml)
and the specific antigen at intervals of 10 d in order to maintain the cell line. After restimula-
tion T cells were cultured in the presence of IL-2 .
Proliferation Assay.
￿
Cells (105) were cultured in round-bottomed 96-well microplates with
RPMI 1640, supplemented with 1% Lewis rat serum, L-glutamine, 2-ME, and antibiotics .
They were incubated with 107 irradiated thymocytes in the presence or absence ofthe specific
antigen in each microtiter well (0.2 ml) for 72 h at 37°C and 5% C02 . ['Hlthymidine (0.2
,uCi/well) was added 18 h before collection. In proliferation assays establishing the MHC
restriction of the antigen-specific proliferation ofNM1 cells either anti-MHC class I (Ox-18)
or class II (Ox-6 ; Camon, Wiesbaden, FRG) mAbs were added to the test wells .
Cytofluorography.
￿
mAbs specific for leukocyte differentiation markers (Camon) as defined
(10) were used as primary antibodies and FITC-conjugated goat anti-mouse Ig (Dianova,
Hamburg, FRG) as secondary antibody reagent . Viable cells (2 x 106 ) were incubated with
the first antibody (1/50) on ice for 30 min. Cells were washed three times with PÀB (PBS,
0.2% sodium azide, 1% BSA) and incubated with the second antibody (1/40) for another
30 min on ice . Surface fluorescence ofthe cells was examined by using the Ortho Cytofluoro-
graphic System H 50 (Ortho Diagnostic Systems, Westwood, MA).
Immunosuppession and Adoptive Transfer .
￿
Lewis rats infected intracerebrally with BD virus
were given a single dose of cyclophosphamide (150 t~g/kg; Endoxan Asta, Bielefeld, FRG)
intraperitoneally 1 d later. Immunosuppressed, infected rats do not show clinical or histopatho-
logical signs of Borna disease, apparently due to the suppression of immunopathologically
relevant immune cells (7) . For adoptive transfer studies, I x 106 to 8 x 106 of the BD
s-specific NMI cell line or asa control a PPD-specificT cell line was injected intravene-
ously into infected immunosuppressed rats 10 d after infection .
Results and Discussion
Immune cells were obtained from the regional lymph node of a rat immunized
with the purified BD virus 38/39-kD antigen, which regularly can be found in the
nucleus and the cytoplasm ofBD virus-infected cells (9) . After restimulation in vitro
with the same antigen a homogeneous cell line, designated NM1, could be main-
tained . The NMI cells responded specifically to the viral antigen in lymphocyte
proliferation assays as documented in Table 1 . The stimulation indices were in the
same range as those after cultivation in the presence ofCon A . On the other hand,
ch as myelin basic protein(MBP), purified protein derivative
ofmycobacteria (PPD), or a homogenate from an uninfected brain (NL-brain) pre-
pared in a similar way as the viral antigen did not stimulate the NMI cells . Cytofluoro
graphic studies withmAbs against leukocyte differentiation markers showed a staining
pattern characteristic for T helper/inducer (CD4+ ) cells . The marker for the CD8
antigen gave no staining reaction (Fig . 1) . In experiments with different rat strains
as donors ofAPCs (data not shown)and by inhibition experiments withmAbs against
respective restriction elements, the established cell line proved to be MHC class II
restricted (Fig. 2) .
The BD virus-specific NMl cells were able to cause meningoencephalitis and then
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TABLE I
Sped Proliferative Response of T Cell Lines Cultured in the Presence of
Ihfferent Antigens
Values represent counts per min and the stimulation indices (SI) ofthe T cell lines NM1, spe-
cific for BD virus, and Z82, specific for MBP (12), cocultured with syngeneic irradiated (3,000
rad) thymocytes. Each probe was measured in triplicates. The standard deviation ranges be-
low 20%. Antigen concentrations: 2.5 tug/ml Con A, 10 Wg/ml PPD, 20 Wg/ml MBP, 30,ug/ml
BD virus-specific antigen (BDV-AG), 40 /ul/ml noninfectious brain homogenate (NL-Brain).
ND, not done.
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FIGURE 1. Cytofluorographic
histograms of the T cell line
NM 1. Surface phenotype ofthe
T cell line NM 1 was assessed
by immunofluorescence using
mouse anti-rat mAbs specific
for leukocyte differentiation
markers (Camon) as defined in
(11) as primary antibodies and
FITC-conjugated goat anti-
mouse Ig (Dianova) as second-
ary antibody reagent. Viable
cells (2 x 106) were incubated
with the first antibody (1/50) on
ice for 30 min. Cells were washed
three times with PAB (PBS,
0.2% sodium azide, 1% BSA)
and incubated with the second
antibody (1/40) for another 30
min on ice. Surface fluorescence
of the cells was examined by
using the Ortho Cytofluoro-
graphic System H 50.
Cell line
Control
medium BD virus-AG NL-brain
Antigens
MBP PPD Con A
cpm cpm SI cpm SI cpm S1 cpm SI cpm SI
NM1 73 12,073 165 105 1 54 1 61 1 16,579 227
Z82 83 52 1 ND 6,435 78 44 1 13,578 164
Control
Lymphocytes 1,026 1,244 1 ND 1,012 1 1,092 1 32,801 321048
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FIGURE 2.
￿
Inhibition ofantigen-specific proliferation by
mAbs specific for MHC class I or class II antigens. Irradi-
ated syngeneic thymus cells (106 cells/well) were incubated
with the appropriate dilution ofa-class I (Ox-18)or a-class
II (Ox-6) mAbs (Camon) in 96-well round-bottomed mi-
crotiter plates and cocultivated with NM 1 cells (104
cells/well) and BDVAg (15 Wg/ml) to give a final volume
of 200 Al/well. Cells were incubated for 72 h at 37°C, 0.2
gCi/well [3H]thymidine was added 18 h before the cells
were harvested. Controls were cultures incubated with (+)
or without (-) BD virus-specific antigen not treated with
the Ox-6 or Ox-18 mAbs.
development ofBD after adoptive transferintoimmunosuppressed BDvirus infected
Lewis rats even if as few as 1 x 106 cells were applied (Table II). The pathological
alterations consist of perivascular and parenchymal infiltrations mainly by
mononuclear cells and by scattered neutrophilic granulocytes preferentially found
in the meninges and the grey matter (Fig. 3). The clinical signs became manifest
already 5 d after transfer. The animals showed loss of weight, exsiccosis, apathy,
weakness, and somnolence. The hyperactive phase, which can be observed in the
usual course ofthe disease, and the production ofvirus-specific antibodies (7) did
not appear in animals that had received the NM1 cells. Injection ofthese cells into
noninfected immunosuppressed rats had no effect. Similarly, a CD4+ cell line
specific for PPD, but irrelevant for BD virus, did not result in the establishment
of disease (Table II).
TABLE II
Adoptive Transfer of CD4+ T Cell Lines into Rats
T cell lines (2 x 105/ml specific for BD virus [NM 1] or PPD [BS.PPD, reference 13]) were
incubated with 10 Rg/ml of the specific antigen and cocultivated with syngeneic irradiated (3,000
rat) thymocytes (2 x 107/ml). After 72 h the cells were collected and washed three times in
Hepes-buffered DME. The cells were transferred intravenously into Lewis rats, which were
infected intracerebrally with BDV into the left brain hemisphere and immunosuppressed 1 d
later by intraperitoneal injection of a single dose of 150 mg/kg cyclophosphamide as indicated
in the table. The transfer was performed 10 d after infection and 9 d after immunosuppres-
sion. (*) Number ofrats showing clinical or pathohistological disorders versus total numbers
of animals .
BDV-
infected
Immuno-
suppressed
Specificity of
transferred cells
Number of
transferred cells
Clinical
manifestations*
Meningo-
encephalitis*
- + BD virus 8 x 106 0/4 0/4
- + BD virus 1 x 106 0/3 0/3
- + PPD 6 x 106 0/3 0/3
+ - - 0 3/3 3/3
+ + - 0 0/3 0/3
+ + BD virus 1 x 106 2/2 2/2
+ + BD virus 4 x 106 3/3 3/3
+ + BD virus 8 x 106 3/3 3/3
+ + PPD 6 x 106 0/4 0/4RICHT ET AL .
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FIGURE 3 . Inflammatory le-
sions in the hippocampus ofim-
munosuppressed, BDVinfected
rats, 5 d after transfer of 8 x
106 virus-specific CD4' T cells,
with predominant mononuclear
perivascular infiltrations extend-
ing into the surrounding neu-
ropil (hematoxylin and eosin,
x 160) .
Thesedata provide direct evidence thatMHC class II-restricted BD virus-specific
cells with theThelper/inducer phenotype represent theT cell subset relevant to the
immunopathological reaction . Since classical cytotoxic CD8 + cells have never been
detected in BD virus-infected animals (our unpublished results), the pathogenesis
ofBD differs from that oflymphocytic choriomeningitis(LCM), which represented
for a long time the paradigm for a virus-induced immunopathological reaction . In
LCM class I-restricted, virus-specific CD8+ cells are the only cell population found
to be essential for the immunopathological event leading to the fatal disease (11).
Furthermore, in contrast to MBP-specific CD4+ T cells found in experimental auto-
immune encephalomyelitis (12) cellular infiltrateswere found predominantly in the
grey matter after transfer of theBD virus-specific CD4+T cells . Thus, BD is likely
to be a unique virus-induced immunopathological disorder affecting the CNS. Ad-
ditionally, BD lends itself exquisitely to investigate the course and consequence of
a virus infection of the CNS, where intensive contact with the immune system is
greatly avoided by strategies ofreplicationand spread ofthe virus exclusively in neu-1050
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ronal cell tissue of the infected host; this is especially true for the presumable intra-
nasal natural infection. The results presented and the finding that cellular infiltrates
in the brain ofdiseased rats have been characterized immunohistologically mainly
as CD4+ T cells, macrophages, and late B cell infiltration (Richt, J. A., manuscript
in preparation) suggests that the pathogenesis ofBD is based on a delayed-type hyper-
sensitivity reaction (DTH).
Summary
A homogeneous T cell line NM1 with Borna disease (BD) virus reactivity could
be established. The NMI cells have been characterized as CD4+ T cells. Adoptive
transfer revealed that this MHC class II-restricted immune cell is responsible for
the immunopathological effect leading to BD, a progressive meningoencephalomyelitis.
Receivedfor publication 4 April 1989 and in revisedform 8June 1989.
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